JW Therapeutics opens $300m Hong Kong IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

JW Therapeutics opens $300m Hong Kong IPO

Jonathan Breen
October 22, 2020 11:00 AM
biotech_microscope_drug_production_adobe_575x375_oct13

JW (Cayman) Therapeutics set its IPO in motion on Thursday, opening the order book for the up to HK$2.3bn ($300m) deal.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC SecuritiesGreen and Social BondsEquity IPOsUBSEquityChinaChina International Capital CorpHong Kong SARICBCAsiaGreater ChinaNortheast AsiaShanghai Pudong Development BankAsia PacificEmerging MarketsSRIGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article